Wednesday, July 8, 2026

pharma · Cancer Anorexia · ARTL

ARTELO BIOSCIENCES

ARTELO BIOSCIENCES patent portfolio — 2 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

La Jolla, USA HQ
2017 Founded
16 Employees
Public company Type
ARTL · NYSE Ticker
Company details
Status
Public
HQ
La Jolla, USA
Founded
2017
Employees
16
Programs
1
Drugs
1
Patents
2
Intelligence · Patents

ARTELO BIOSCIENCES patents

2 pharmaceutical patents indexed for ARTELO BIOSCIENCES. 0 expire within 24 months.

ARTELO BIOSCIENCES has 2 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. US 11364202

    Solid forms of cannabidiol and uses thereof

    Expires Mon Jun 16 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 10604467

    Solid forms of cannabidiol and uses thereof

    Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does ARTELO BIOSCIENCES have?

2 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do ARTELO BIOSCIENCES patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.